BLOG
Final FDA Guidance for Federal Food, Drug, and Cosmetic Act
Final FDA Guidance: Federal Food, Drug, and Cosmetic Act Written-by: Deneen Fumich, RPh On March 16, 2023, FDA announced: “the availability of a final guidance for industry entitled Definitions of Suspect Product and Illegitimate Product for Verification Obligations...
Recent Articles
Client Success Department Announcement
Client Success Department Announcement A letter from our COO, Nathan Fox, regarding the introduction of our new Client Success Department and Client...
FDA Proposed Rules: Pharma Solutions’ Comment Submission
FDA Proposed Rules: Pharma Solutions' Comment Submission Written-by: Sumeet Singh, CEO Preemption Section 585(b): The Proposed Rules suggest that...
Nine States With Upcoming September Licensing Deadlines
Nine States With Upcoming September Licensing Deadlines Written-by: Maria Pennings, Director of State Licensing The September 30th deadline for...
How Puerto Rico’s New License Requirement Affects Industry
How Puerto Rico’s New License Requirement Affects Industry Written-by: Sumeet Singh, CEO Pharma Solutions has received updates from the Puerto Rico...
Review of FDA July 2022 DSCSA Draft Guidance on Identifying Trading Partners
Review of FDA July 2022 DSCSA Draft Guidance on Identifying Trading Partners Written-by: Sumeet Singh, CEO As we rocket towards the Event Horizon of...
Part 4: Macro-Insights for Industry
Part 4: Macro-Insights for Industry Written-by: Sumeet Singh, CEO 5 Macro-Insights for Industry The FDA Proposed Rules are poised to have sweeping...
